179 related articles for article (PubMed ID: 16499081)
1. [Synthesis of isothioureas derived from tetrahydroisoquinoline and NOS inhibitory activity].
Zhang DY
Yao Xue Xue Bao; 2005 Nov; 40(11):988-93. PubMed ID: 16499081
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis and bioactivity of 2-arylimino-4-thiazolidones].
Zhang DY; Xiang H; Xu YG; Hua WY
Yao Xue Xue Bao; 2006 Sep; 41(9):825-9. PubMed ID: 17111827
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and nNOS inhibitory activity of benzenealkyl isothiourea compounds].
Xu YG; Zhang JX; Hua WY; Zhu DY
Yao Xue Xue Bao; 2003 Aug; 38(8):586-91. PubMed ID: 14628448
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimicrobial and nitric oxide synthase inhibitory activities of novel isothiourea derivatives.
Kazimierczuk Z; Chalimoniuk M; Laudy AE; Moo-Puc R; Cedillo-Rivera R; Starosciak BJ; Chrapusta SJ
Arch Pharm Res; 2010 Jun; 33(6):821-30. PubMed ID: 20607486
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 3-benzyl-1-methyl- and 1-methyl-3-phenyl-isothioureas as potential inhibitors of iNOS.
Paesano N; Marzocco S; Vicidomini C; Saturnino C; Autore G; De Martino G; Sbardella G
Bioorg Med Chem Lett; 2005 Feb; 15(3):539-43. PubMed ID: 15664809
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents.
Küçükgüzel I; Tatar E; Küçükgüzel SG; Rollas S; De Clercq E
Eur J Med Chem; 2008 Feb; 43(2):381-92. PubMed ID: 17583388
[TBL] [Abstract][Full Text] [Related]
7. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity.
Southan GJ; Szabó C; Thiemermann C
Br J Pharmacol; 1995 Jan; 114(2):510-6. PubMed ID: 7533622
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and bioactivity of N- [4- ( benzimidazole-2-thio) phenyl] -N'-alkyl guanidine derivatives].
Xu YG; Xing AM; Hong M; Sun XY
Yao Xue Xue Bao; 2007 Feb; 42(2):152-6. PubMed ID: 17518042
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of urea and thiourea derivatives and their inhibitory activities on lipopolysaccharide-induced NO production.
Kim YJ; Ryu JH; Cheon YJ; Lim HJ; Jeon R
Bioorg Med Chem Lett; 2007 Jun; 17(12):3317-21. PubMed ID: 17467989
[TBL] [Abstract][Full Text] [Related]
10. (1) H and (13) C NMR spectral assignment of N,N'-disubstituted thiourea and urea derivatives active against nitric oxide synthase.
Chayah M; Camacho ME; Carrión MD; Gallo MA
Magn Reson Chem; 2016 Oct; 54(10):793-799. PubMed ID: 27173052
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticonvulsant activity of new N-(alkyl/sub-stituted aryl)-N'-[4-(5-cyclohexylamino)-1,3,4-thiadiazole-2-yl)phenyl]thioureas.
Karakus S; Koçyiğit-Kaymakcioğlu B; Toklu HZ; Aricioglu F; Rollas S
Arch Pharm (Weinheim); 2009 Jan; 342(1):48-53. PubMed ID: 19035387
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antitumor evaluation of a new series of N-substituted-thiourea derivatives.
Li J; Tan JZ; Chen LL; Zhang J; Shen X; Mei CL; Fu LL; Lin LP; Ding J; Xiong B; Xiong XS; Liu H; Luo XM; Jiang HL
Acta Pharmacol Sin; 2006 Sep; 27(9):1259-71. PubMed ID: 16923349
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and anti-HCV activity of thiourea compounds.
Kang IJ; Wang LW; Lee CC; Lee YC; Chao YS; Hsu TA; Chern JH
Bioorg Med Chem Lett; 2009 Apr; 19(7):1950-5. PubMed ID: 19251415
[TBL] [Abstract][Full Text] [Related]
14. The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship.
Buchholz M; Heiser U; Schilling S; Niestroj AJ; Zunkel K; Demuth HU
J Med Chem; 2006 Jan; 49(2):664-77. PubMed ID: 16420052
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of N-aryl isothioureas as a novel class of gastric H(+) /K(+) -ATPase inhibitors.
Ma C; Wu A; Wu Y; Ren X; Cheng M
Arch Pharm (Weinheim); 2013 Dec; 346(12):891-900. PubMed ID: 24301963
[TBL] [Abstract][Full Text] [Related]
16. Discovery and SAR of cyclic isothioureas as novel NPY Y1 receptor antagonists.
Sun ZY; Zhu Z; Ye Y; McKittrick B; Czarniecki M; Greenlee W; Mullins D; Guzzi M
Bioorg Med Chem Lett; 2009 Dec; 19(23):6801-5. PubMed ID: 19864135
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity, and DNA-topoisomerase inhibitory activity of new asymmetric ureas and thioureas.
Esteves-Souza A; Pissinate K; Nascimento Mda G; Grynberg NF; Echevarria A
Bioorg Med Chem; 2006 Jan; 14(2):492-9. PubMed ID: 16183295
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase by isothioureas: cardiovascular and antinociceptive effects.
Handy RL; Wallace P; Moore PK
Pharmacol Biochem Behav; 1996 Oct; 55(2):179-84. PubMed ID: 8951952
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of N-alkyl-S-[3-(piperidin-1-yl)propyl]isothioureas: high affinity and human/rat species-selective histamine H(3) receptor antagonists.
Harusawa S; Sawada K; Magata T; Yoneyama H; Araki L; Usami Y; Hatano K; Yamamoto K; Yamamoto D; Yamatodani A
Bioorg Med Chem Lett; 2013 Dec; 23(23):6415-20. PubMed ID: 24140447
[TBL] [Abstract][Full Text] [Related]
20. Sustainable three-component synthesis of isothioureas from isocyanides, thiosulfonates, and amines.
Mampuys P; Zhu Y; Vlaar T; Ruijter E; Orru RV; Maes BU
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12849-54. PubMed ID: 25223494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
